Who backs TORL BioTherapeutics?
19 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| Alexandria Venture Investments | Other |
| Goldman Sachs Asset Management | Other |
| Blue Owl Capital | — |
| Moore Strategic Ventures | Venture capital |
| Perceptive Advisors | Hedge fund |
| Bristol-Myers Squibb | — |
| Moore Capital Management | Hedge fund |
| Deep Track Capital | Venture capital |
| Hyperlink Ventures | Venture capital |
| + 9 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for TORL BioTherapeutics
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 19 firms already write checks for companies like TORL BioTherapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.